OPSUMIT
"OPSUMIT" is a word and design mark owned by Actelion Pharmaceuticals Ltd., filed at the USPTO on April 18, 2021. It is registered and covers class 44 (Medical, Beauty, and Agricultural).
- Status
- Registered
- Since April 12, 2022
- Filed
- April 18, 2021
- Registered
- April 12, 2022
- Expires
- Not recorded
- Application no.
- 90653209
- Registration no.
- 6697798
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 1 class
Who owns OPSUMIT
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Actelion Pharmaceuticals Ltd.
Allschwil, Switzerland
Representative
Cheryl Foytlin
Johnson & Johnson
What the mark covers
The products and services OPSUMIT is filed for, grouped by Nice class.
Providing medical information regarding pharmaceutical products and healthcare to healthcare professionals and patients
What has happened so far
Steps recorded by the USPTO, newest first.
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Examiner's amendment entered
- Correspondence e-mailed
- Examiners amendment -written
- Teas/email correspondence entered
- Correspondence received in law office
8 earlier steps on the official record.
About OPSUMIT
Who owns the trademark "OPSUMIT"?
The USPTO trademark "OPSUMIT" (application 90653209) is owned by Actelion Pharmaceuticals Ltd.
What is the status of "OPSUMIT"?
Its status at the USPTO is: registered.
When was "OPSUMIT" registered?
It was registered on April 12, 2022.
Get this data via the API
Everything on this page comes from the Signa API. Pull OPSUMIT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2d3d-ca50-7799-9541-2449c15e5e53
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2d3d-ca50-7799-9541-2449c15e5e53",
"object": "trademark",
"mark_text": "OPSUMIT",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "90653209",
"filing_date": "2021-04-18",
"nice_classes": [
44
],
"owners": [
{
"name": "Actelion Pharmaceuticals Ltd.",
"entity_id": "ent_019eb702-a943-779f-b91a-3034519ba72d"
}
]
}